Showing results (261-270 of 481) with videos related to
Sort By:
Pageof 49
Cells|November 21, 2020
Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation ModelIlhan Inci, Stephan Arni, Ilker Iskender, et al.Frontiers in Oncology|December 22, 2025
CD26 as a potential therapeutic target for lung adenocarcinomaWolfgang Jungraithmayr, Birte Ohm, Martina Haberecker, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 25, 2024
Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastasesRaphael S Werner, Markus Rechsteiner, Holger Moch, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 4, 2021
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesotheliomaOlivia Lauk, Miriam Patella, Thomas Neuer, et al.Bioinformatics (Oxford, England)|September 14, 2010
Semi-supervised recursively partitioned mixture models for identifying cancer subtypesDevin C Koestler, Carmen J Marsit, Brock C Christensen, et al.The Annals of Thoracic Surgery|December 12, 2003
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancerKimberly A Moore, Carlos M Mery, Michael T Jaklitsch, et al.Journal of Clinical Bioinformatics|September 3, 2011
Peripheral blood gene expression profiles in COPD subjectsSoumyaroop Bhattacharya, Shivraj Tyagi, Sorachai Srisuma, et al.Plos One|February 25, 2012
A novel classification of lung cancer into molecular subtypesLisandra West, Smruti J Vidwans, Nicholas P Campbell, et al.Seminars in Thoracic and Cardiovascular Surgery|July 4, 2021
Esophagectomy for Esophageal Cancer Performed During the Early Phase of the COVID-19 PandemicDaniel P Dolan, Scott J Swanson, Daniel N Lee, et al.Journal of Surgical Oncology|December 1, 2022
Hyperthermic intraoperative chemotherapy (HIOC) for Stage IVa thymic malignancy may improve 5-year disease-free survivalDaniel P Dolan, Emily Polhemus, Daniel N Lee, et al.Pageof 49